NEVER! Two things, one is licensing of Prurisol which will provide funds for Phase 2 Kevetrin trials! Other lesser known, CTIX has access to funds from principal of very large hedge fund. We have discussed this same topics for months, dilution hurts nobody more than Leo and Dr Menon. Don't see major dilution happening, IMHO . . . this is not a typical small biopharma....look at their history and look who has underwritten everything to this point (the principals) . . . unheard of!!!! They have proved over and over by word and deed.... their shareholders matter!